Stem Cells and Cancer Stem Cells, Volume 11 (Record no. 93998)

000 -LEADER
fixed length control field 05899nam a22004815i 4500
001 - CONTROL NUMBER
control field 978-94-007-7329-5
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140220082530.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 131021s2014 ne | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789400773295
-- 978-94-007-7329-5
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-94-007-7329-5
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC261-271
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 614.5999
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hayat, M.A.
Relator term editor.
245 10 - TITLE STATEMENT
Title Stem Cells and Cancer Stem Cells, Volume 11
Medium [electronic resource] :
Remainder of title Therapeutic Applications in Disease and injury /
Statement of responsibility, etc edited by M.A. Hayat.
264 #1 -
-- Dordrecht :
-- Springer Netherlands :
-- Imprint: Springer,
-- 2014.
300 ## - PHYSICAL DESCRIPTION
Extent XXXVIII, 280 p. 26 illus., 18 illus. in color.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# - SERIES STATEMENT
Series statement Stem Cells and Cancer Stem Cells,
International Standard Serial Number 2215-0994 ;
Volume number/sequential designation 11
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Preface. I. Embryonic stem cells -- Maintenance of human embryonic stem cell identity and Inhibition of extraembryonic differentiation: Role of cnot1, cnot2 and cnot3.-Investigating the role of the embryonic stem cell self-renewal gene nanog in neoplastic processes -- Derivation and expansion of human embryonic stem cells under xeno-free, defined conditions -- Self-renewal of naïve state mouse embryonic stem cells: Role of lacdinac in lif/stat3 signaling -- Cancer gene therapy potential of neural stem cells derived from human embryonic stem cells and induced pluripotent stem cells. II. Cancer stem cells -- The role of cancer stem(-like) cells and epithelial-to-mesenchymal transition in spreading head and neck squamous cell carcinoma -- Glioma propagating cells show enhanced chemoresistance and radioresistance (an update) -- Chemical genomic approaches to eradicate leukemia stem cells -- Isolation of cancer stem cells showing drug resistance in the human epithelia ovarian cancer -- Cancer stem cells in pediatric sarcomas -- Cancer stem cells derived from mouse induced pluripotent stem cells -- Stemness regulation of somatic cancer cells -- Induced differentiation of brain tumour stem cells -- Role of microenvironment in regulating stem cell and tumor initiating cancer cell behavior and its potential therapeutic implications -- Identification of ovarian cancer stem cells: molecular pathways. III. Hematopoietic stem cells -- Hematopoietic stem cells and bone regeneration -- Children with solid tumors: identification of ematopoietic and endothelial progenitor cells as biomarkers -- Pediatric neuroblastoma: combined treatment with monoclonal antibody and cytokines preceded by matopoietic stem cell transplantation -- Autologous and allogeneic hematopoieitic cell transplantation: risk of second malignancies. IV. Neural stem cells -- Treatment of injured spinal cord: engraftment of neural stem cells -- Spinal cord injury ngineering using neural stem cells -- Endogenous regenerative potential of neural stem/progenitor cells of the newborn brain (an overview).Index.
520 ## - SUMMARY, ETC.
Summary, etc Volume 11 in this series discusses therapeutic applications of stem cells in disease and tissue injury. Coverage includes pluripotent stem cells, which can give rise to the endodermal, ectodermal, and mesodermal lineages; multipotent stem cells, which can generate all cells in a particular lineage and unipotent stem cells, which can give rise to only one cell type. This volume also examines cancer stem cells, tumor-initiating cells which possesses the capacity of self-renewal and can give rise to the heterogeneous lineages of cancer cells that comprise the tumor. Coverage extends to molecular mechanisms underlying the derivation and expansion of human embryonic stem cells, the role of specific proteins in the maintenance and inhibition of extraembryonic differentiation of these cells and the role of signaling responsible for the self-renewal of mouse embryonic stem cells. Nine chapters discuss the clinical importance of cancer stem cells, encompassing glioma, leukemia, ovarian cancer, pediatric sarcomas and head and neck squamous cell carcinoma. The role of cancer stem cells is also elucidated in epithelial-to-mesenchymal transition in spreading head and neck squamous cell carcinoma. The book goes on to survey therapeutic application of stem cells of hematopoietic and non-hematopoietic origin for regeneration of bones, including in osteoporotic bone disease; to illuminate the application of hematopoietic stem cells in bone regeneration and to discuss their use as a biomarker to facilitate determination of a treatment. The contributors review cells as biomarkers for pediatric solid tumors, and weigh the advantages and limitations of hematopoietic stem cell transplantation. Also included are details of neural stem cell engraftment in the injured spinal cord; the regenerative potential of neural stem/progenitor cells of newborns and cancer gene therapy potential using neural stem cells. Like the preceding volumes in the series, this book is distinguished for its comprehensive approach, its distinguished roster of 58 contributors representing 10 different countries and its thorough review of leading-edge technology and methods.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Science (General).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine/Public Health, general.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Science, general.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9789400773288
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Stem Cells and Cancer Stem Cells,
-- 2215-0994 ;
Volume number/sequential designation 11
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-94-007-7329-5
912 ## -
-- ZDB-2-SBL

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue